Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
Oryzon Genomics, S.A.
ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in Extensive Stage Small Cell Lung Cancer
February 10, 2026
ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan
February 2, 2026
←
Previous Page
1
2